- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 20, 2026 | 125.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 121M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 69.48M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $6.14M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $2.31M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$17.76M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$3.17M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $5.06M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $1.47M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $53.27M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $584K |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $83.17M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $47.75M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $207.35M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $279.57M |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $55.97M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $289M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $204.15M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $70.37M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $32.7M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $288.65M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $235.12M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $308.74M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $399.92M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $587.67M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $498.02M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.06 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $5.26M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $1.53M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$7.12M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$8.46M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$24.89M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$7.95M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $1.67M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $327K |
| Revenue | Q1 2026 · Mar 31, 2026 | $4.18M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $1.1M |
| Sga Expense | Q1 2026 · Nov 30, 2025 | $2.6M |